Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQESPERION THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ESPR - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ -433.51M | $ 391.15M | 0 |
| 3/31/2025 | $ -426.21M | $ 176.99M | 0 |
| 12/31/2024 | $ -388.72M | $ 334.36M | 0 |
| 9/30/2024 | $ -370.21M | $ 415.74M | 0 |
| 6/30/2024 | $ -344.22M | $ 361.05M | 0 |
| 3/31/2024 | $ -294.3M | $ 449.02M | 0 |
| 12/31/2023 | $ -454.99M | $ 536.65M | 0 |
| 9/30/2023 | $ -410M | $ 117.13M | 0 |
| 6/30/2023 | $ -371.98M | $ 180.82M | 0 |
| 3/31/2023 | $ -329.66M | $ 134.49M | 0 |
Key Performance Insights, Last 5 Years
- ESPERION THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 90.19.
- Over the past 5 years, ESPERION THERAPEUTICS INC's average P/B has been 90.19.
- The median P/B for ESPERION THERAPEUTICS INC during this period was 90.19
- ESPERION THERAPEUTICS INC reached its highest P/B over the past 5 years at 90.19.
- The lowest P/B recorded by ESPERION THERAPEUTICS INC in the same timeframe 90.19
ESPERION THERAPEUTICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for ESPERION THERAPEUTICS INC is calculated as follows: Market Cap [ $ 808.14M ] / Equity [ $ 8.96M ]
(=) P/B [ 90.19 ] ESPR - Price to Book, Last 5 years
90.19
Minimum
Sep 30, 2020
90.19
Maximum
Sep 30, 2020
90.19
Average
90.19
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |